Compounds > nipradilol
Page last updated: 2024-08-25

nipradilol and Hypertension

nipradilol has been researched along with Hypertension in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inada, H; Ishimitsu, T; Matsuoka, H; Minami, J; Ono, H1
Hasuike, Y; Hiraoka, K; Inoue, T; Itahana, R; Izumi, M; Miyagawa, K; Nakanishi, T; Nishihara, F; Takamitsu, Y1
Fujii, M; Nakamura, M; Shimizu, S; Shirasawa, Y; Uchida, Y1
Awata, T; Inaba, M; Katayama, S; Kosegawa, I; Morita, T1
Mikami, H; Ogihara, T1
Kawashima, K; Sokabe, H; Watanabe, TX1

Other Studies

6 other study(ies) available for nipradilol and Hypertension

ArticleYear
Nipradilol prevents L-NAME-exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHR.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2002, Volume: 25, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Blood Pressure; Caspase 3; Caspases; Hypertension; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Proliferating Cell Nuclear Antigen; Propanolamines; Rats; Rats, Inbred SHR; Rats, Wistar

2002
A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol.
    Nephron. Physiology, 2003, Volume: 93, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Cyclic GMP; Enzyme Inhibitors; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrites; Propanolamines; Propranolol; Proteinuria; Rats; Rats, Inbred F344; Renin

2003
Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
    Archives internationales de pharmacodynamie et de therapie, 1983, Volume: 262, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Guinea Pigs; Heart Rate; Hypertension; In Vitro Techniques; Myocardial Contraction; Norepinephrine; Potassium; Propanolamines; Rats; Rats, Inbred Strains; Vasoconstriction; Vasodilator Agents

1983
Effect of the vasodilatory beta-blocker, nipradilol, and Ca-antagonist, barnidipine, on insulin sensitivity in patients with essential hypertension.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1998, Volume: 20, Issue:7

    Topics: Adrenergic beta-Antagonists; Blood Pressure; Calcium Channel Blockers; Female; Glucose Clamp Technique; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Nifedipine; Propanolamines; Vasodilator Agents

1998
[Clinical application of adrenoceptor blockers in the treatment of hypertension].
    Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 47, Issue:9

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Humans; Hypertension; Labetalol; Prazosin; Propanolamines; Quinazolines

1989
An analysis of blood pressure effects of nipradilol and prizidilol in normotensive and spontaneously hypertensive rats.
    Japanese journal of pharmacology, 1985, Volume: 38, Issue:3

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Hypertension; Propanolamines; Pyridazines; Rats; Rats, Inbred SHR; Renin; Time Factors

1985